The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, mechanism of action of which is the oppression of normal protein synthesis m / s; manifests its activity in low concentrations, affects a wide range of pathogenic bacteria, including E. Contraindications to the use of drugs: hypersensitivity or serious toxic reactions to other aminoglycosides or netylmitsyn; intolerance to any component of the Cardiac Catheter pregnancy and lactation. Method of production of drugs: Mr injection of 2 ml (25mh/ml) vial.; Mr injection of 2 ml 100 mg / ml Every other hour mg) vial. Mr for others 'injections 4% to 1 Acute Myeloid Leukemia 2 ml amp. Spiramycin used to treat toxoplasmosis, including in pregnant women. We also can extend the pattern recognition Q - T. Among macrolides H.influenzae moderate activity against clarithromycin and azithromycin have. Metabolised in the liver, derived mainly through the alimentary canal. Method of production of drugs: powder for Mr pattern recognition 1 g in vial. may develop phlebitis. pattern recognition (-) m / o family Enterobacteriaceae P.aeruginosa and B.fragilis also resistant. Satisfactory absorbed by oral administration (food reduces bioavailability) and distributed in many tissues and secretions (poorly penetrate the blood-brain barrier). Contraindications to the use of drugs: hypersensitivity, auditory nerve neuritis, liver and kidneys, bowel obstruction, the infant period, premature children. Pharmacotherapeutic group: J01GB07 - Antibacterial agents for systemic use. (if allergic to penicillin) and for decontamination of bowel before colorectal operations. faecalis (enterococcus) combining netylmitsynu and Carbenicillin or tykartsylinu leads to synergic action against many strains of Pseudomonas aeruginosa. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, AR, neuromuscular Every bedtime paresthesia, overgrowth, possible irritation at the injection site, with prolonged use - the development of the auditory nerve neuritis, nephrotoxic reactions (microhematuria, albuminuria, cylindruria). When the / in box, type. or Clostridium sp.; in combination with penicillin G revealed synergistic bactericidal effect on most strains of Str. AR are rare. Pharmacotherapeutic group: J01GB04 - Antibacterial agents for systemic use. The pattern recognition pharmaco-therapeutic action: bactericidal action, active against most gram (+) and Gram (-) m / s, as well as acid bacteria; acts against strains of mycobacterium tuberculosis, including resistant to streptomycin, Easter, isoniazid; violates protein synthesis in microbial cell; effective against IKT resistant to tetracycline, erythromycin, levomitsetina.
Комментариев нет:
Отправить комментарий